RheumNow Podcast – Sweet Lies or Hard Truths? (2.26.2021)
Dr. Jack Cush reviews and discusses the news and Journal reports from the past week on RheumNow.com.
Read ArticleDr. Jack Cush reviews and discusses the news and Journal reports from the past week on RheumNow.com.
Read ArticleLinks:
A recent metanalysis of studies suggest you may be able to use certain clinical factors to stratify cancer risk in patients with idiopathic inflammatory myopathies (IIMs).
Read ArticleDr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com, with more than a dozen items to discuss on this week's podcast.
Read ArticleLinks:
Dr. John Cush @RheumNow( View Tweet )
Links:
Dr. John Cush @RheumNow( View Tweet )
Links:
2020 was historic, memorable and game-changing. Under the cloud of COVID-19, there were many significant and memorable advances and setbacks for the rheumatology world. In our accounting of most read articles for 2020, (not surprisingly) 17/20 were COVID-related. Below, are our top news items
Read ArticleThe ProDERM study design and outcomes are previewed in Medicine; and as promised the results were revealed at ACR Convergence in November 2020 showing that IVIg is safe, effective and superior to placebo i(PBO) in patients with dermatomyositis (DM).
Read ArticleLinks:
Dr. John Cush @RheumNow( View Tweet )
Links:
Dr. John Cush @RheumNow( View Tweet )
Links:
Meral K. El Ramahi, MD @MeralElRamahiMD( View Tweet )
Meral K. El Ramahi, MD @MeralElRamahiMD( View Tweet )
Meral K. El Ramahi, MD @MeralElRamahiMD( View Tweet )
Winning is everything – in football and in medicine. Rheumatologists have achieved many successes but still struggle to win against a handful of rheumatic foes. This retrospective examines past wins and losses and helps us to look ahead to a new season.
Read Post